These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 2785325

  • 1. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W.
    Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A, Nastić-Mirić D, Milikić V, Babić D, Pejcić I, Kostić M, Paripović V, Jovanović O, Kruscić D, Mancić J.
    Srp Arh Celok Lek; 1996 Nov; 124(9-10):227-31. PubMed ID: 9102853
    [Abstract] [Full Text] [Related]

  • 5. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
    Cibulka R, Racek J, Pikner R, Rajdl D, Trefil L, Vesela E, Studenovska M, Siroka R.
    Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Aug; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 8. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
    Klein JR, Grunewald RW, Steffgen J, Franz HE.
    Adv Perit Dial; 1991 Aug; 7():225-9. PubMed ID: 1680431
    [Abstract] [Full Text] [Related]

  • 9. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi F.
    Miner Electrolyte Metab; 1989 Aug; 15(5):295-302. PubMed ID: 2811788
    [Abstract] [Full Text] [Related]

  • 10. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J.
    Scand J Urol Nephrol Suppl; 1983 Aug; 70():1-63. PubMed ID: 6351238
    [Abstract] [Full Text] [Related]

  • 11. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
    Stĕpán JJ, Lachmanová J, Straková M, Pacovský V.
    Bone Miner; 1987 Nov; 3(2):177-83. PubMed ID: 3509796
    [Abstract] [Full Text] [Related]

  • 12. Increased serum osteocalcin levels in elderly females with vitamin D deficiency.
    Pietschmann P, Woloszczuk W, Pietschmann H.
    Exp Clin Endocrinol; 1990 Apr; 95(2):275-8. PubMed ID: 2365024
    [Abstract] [Full Text] [Related]

  • 13. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P, Hrubý M.
    Cas Lek Cesk; 1993 Nov 22; 132(22):681-3. PubMed ID: 8293434
    [Abstract] [Full Text] [Related]

  • 14. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H, Schatz C, Pralle H, Ullmann J, Schatz H.
    Dtsch Med Wochenschr; 1985 Sep 20; 110(38):1442-6. PubMed ID: 3875469
    [Abstract] [Full Text] [Related]

  • 15. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S, Traberg H, Raja R, Poser J.
    J Clin Endocrinol Metab; 1985 Jun 20; 60(6):1253-6. PubMed ID: 3889031
    [Abstract] [Full Text] [Related]

  • 16. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL, Page J, Kerr DN, Walls J, Moorhead J, Crockett RE, Franz H, Ritz E.
    Q J Med; 1970 Jul 20; 39(155):359-76. PubMed ID: 5478506
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N.
    Nihon Jinzo Gakkai Shi; 1991 Jun 20; 33(6):587-96. PubMed ID: 1920939
    [Abstract] [Full Text] [Related]

  • 18. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.
    Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli G.
    Miner Electrolyte Metab; 1988 Jun 20; 14(4):201-7. PubMed ID: 3264876
    [Abstract] [Full Text] [Related]

  • 19. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G, Mazzaferro S, Bonucci E, Ballanti P, Massimetti C, Donato G, Landi A, Smacchi A, Della Rocca C, Cinotti GA.
    Miner Electrolyte Metab; 1986 Jun 20; 12(5-6):375-82. PubMed ID: 3492662
    [Abstract] [Full Text] [Related]

  • 20. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL, Chan TT, Ho YW, Lam SH.
    Arch Surg; 2007 Jul 20; 142(7):644-8. PubMed ID: 17638802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.